What is Seed?
Seed develops, manufactures, and sells probiotic bacteria supplements for consumers. Headquartered in Venice, California, the company operates within the burgeoning market for dietary supplements, specifically targeting the growing consumer interest in gut health and microbiome science. Their product offerings aim to provide scientifically-backed probiotic solutions to enhance consumer well-being.
How much funding has Seed raised?
Seed has raised a total of $40M across 1 funding round:
Series A
$40M
Series A (2021): $40M with participation from The Craftory, Founders Fund, 8VC, ARTIS Ventures, and GISEV
Key Investors in Seed
The Craftory
The Craftory is a consumer venture capital fund based in London and San Francisco, focusing on investing in consumer brands that have a positive social impact. They provide growth capital and support to visionary entrepreneurs aiming to drive positive change in the CPG sector.
Founders Fund
Founders Fund invests in the world's most important and valuable companies across all geographies, sectors and stages. The firm's partners have a history of backing transformative companies like SpaceX and Palantir.
8VC
8VC is a leading technology investment firm that backs industry-transforming companies, particularly in smart enterprise platforms across sectors like financial services, healthcare, and logistics. Their partners have a strong track record as founders of successful tech companies.
What's next for Seed?
The recent major strategic investment signals a pivotal phase for Seed, likely enabling expansion of manufacturing capabilities, further research and development into novel probiotic strains, and broader market penetration. With substantial backing, Seed is poised to scale its operations, enhance its product pipeline, and solidify its position as a leader in the premium probiotic supplement market. Future growth may involve strategic partnerships or diversification into related health categories.
See full Seed company page
